Patient and Parent Knowledge, Understanding, and Concerns After a New Diagnosis of Ehlers Danlos Syndrome

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Specialty General Medicine

Date 2024 Dec 30

PMID 39736684

Authors

Jordan T Jones

Lora L Black

William R Black

Affiliations

Soon will be listed here.

Abstract

Introduction: After diagnosis of Ehlers Danlos Syndrome (EDS), it is unclear what information patients and parents need and understand about EDS. The objective of this study is to characterize patient and parent knowledge and concerns about EDS after a diagnosis of EDS is made to determine patient and parent concerns and identify barriers that cause discomfort with the diagnosis.6 METHODS: A convenience sample of patient and parent dyads were recruited after new diagnosis of EDS. Patients and parents completed questionnaires that assessed knowledge, comfort, and barriers of EDS before and after diagnosis, EDS education materials accessed, and additional clinical needs and concerns.

Results: Seventy-two dyads completed the survey.

Conclusion: Many respondents actively seek information on the diagnosis and management of EDS. Parents and patients look for information about EDS differently. Parents have more concerns after diagnosis and both want well-constructed, empirically supported educational materials delivered via multiple modalities, which makes clinical guidelines more essential.

References

Jones J, Black W . Provider Knowledge and Experience in Care, Management, and Education of Pediatric Ehlers-Danlos syndrome. Glob Pediatr Health. 2022; 9:2333794X221112841. PMC: 9305803. DOI: 10.1177/2333794X221112841. View

Halverson C, Clayton E, Garcia Sierra A, Francomano C . Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey. Am J Med Genet C Semin Med Genet. 2021; 187(4):416-424. DOI: 10.1002/ajmg.c.31935. View

Jones J, Black W, Cogan W, Callen E . Resource utilization and multidisciplinary care needs for patients with Ehlers-Danlos syndrome. Mol Genet Genomic Med. 2022; 10(11):e2057. PMC: 9651604. DOI: 10.1002/mgg3.2057. View

Malfait F, Castori M, Francomano C, Giunta C, Kosho T, Byers P . The Ehlers-Danlos syndromes. Nat Rev Dis Primers. 2020; 6(1):64. DOI: 10.1038/s41572-020-0194-9. View

Bloom L, Byers P, Francomano C, Tinkle B, Malfait F . The international consortium on the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017; 175(1):5-7. DOI: 10.1002/ajmg.c.31547. View

Fikree A, Chelimsky G, Collins H, Kovacic K, Aziz Q . Gastrointestinal involvement in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017; 175(1):181-187. DOI: 10.1002/ajmg.c.31546. View

Engelbert R, Juul-Kristensen B, Pacey V, De Wandele I, Smeenk S, Woinarosky N . The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017; 175(1):158-167. DOI: 10.1002/ajmg.c.31545. View

Ashtari S, Taylor A . The Internet Knows More Than My Physician: Qualitative Interview Study of People With Rare Diseases and How They Use Online Support Groups. J Med Internet Res. 2022; 24(8):e39172. PMC: 9459833. DOI: 10.2196/39172. View

Martin V, Neilson D . Joint hypermobility and headache: the glue that binds the two together--part 2. Headache. 2014; 54(8):1403-11. DOI: 10.1111/head.12417. View

10.

Castori M, Camerota F, Celletti C, Grammatico P, Padua L . Ehlers-Danlos syndrome hypermobility type and the excess of affected females: possible mechanisms and perspectives. Am J Med Genet A. 2010; 152A(9):2406-8. DOI: 10.1002/ajmg.a.33585. View

11.

Shultz S, Wideman L, Montgomery M, Beasley K, Nindl B . Changes in serum collagen markers, IGF-I, and knee joint laxity across the menstrual cycle. J Orthop Res. 2012; 30(9):1405-12. PMC: 3371148. DOI: 10.1002/jor.22093. View

12.

Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J . The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017; 175(1):8-26. DOI: 10.1002/ajmg.c.31552. View

13.

Halverson C, Doyle T, Vershaw S . Social media use by patients with hypermobile Ehlers-Danlos syndrome. Mol Genet Genomic Med. 2024; 12(6):e2467. PMC: 11165341. DOI: 10.1002/mgg3.2467. View

14.

Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A . A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017; 175(1):148-157. DOI: 10.1002/ajmg.c.31539. View

15.

Jones J, Black W, Moser C, Rush E, Malloy Walton L . Gender dysphoria in adolescents with Ehlers-Danlos syndrome. SAGE Open Med. 2023; 10:20503121221146074. PMC: 9806399. DOI: 10.1177/20503121221146074. View

16.

Langhinrichsen-Rohling J, Lewis C, McCabe S, Lathan E, Agnew G, Selwyn C . They've been BITTEN: reports of institutional and provider betrayal and links with Ehlers-Danlos Syndrome patients' current symptoms, unmet needs and healthcare expectations. Ther Adv Rare Dis. 2023; 2:26330040211022033. PMC: 10032464. DOI: 10.1177/26330040211022033. View

17.

Joseph A, Joseph S, Francomano C, Kontis T . Characteristics, Diagnosis, and Management of Ehlers-Danlos Syndromes: A Review. JAMA Facial Plast Surg. 2017; 20(1):70-75. DOI: 10.1001/jamafacial.2017.0793. View

18.

Black W, Black L, Jones J . Barriers to the Diagnosis, Care, and Management of Pediatric Patients With Ehlers-Danlos Syndrome in the United States: A Qualitative Analysis. Glob Pediatr Health. 2023; 10:2333794X231212081. PMC: 10666714. DOI: 10.1177/2333794X231212081. View

19.

Knight D, Confiado S, Bruno K, Fairweather D, Seymour-Sonnier A, Jain A . Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned. SN Compr Clin Med. 2022; 4(1):138. PMC: 9255530. DOI: 10.1007/s42399-022-01218-w. View

20.

Adams R . Improving health outcomes with better patient understanding and education. Risk Manag Healthc Policy. 2012; 3:61-72. PMC: 3270921. DOI: 10.2147/RMHP.S7500. View